Pidilite Industries reported a 30.3% year-on-year increase in consolidated net profit to ₹884 crore for the quarter ended June 30, 2026 (Q1FY27), driven by robust underlying volume growth of 11.3% and effective price realization. The company's consolidated revenue from operations rose 21.3% to ₹4,541 crore, surpassing the prior year's ₹3,742 crore. Demand remained resilient across urban and rural markets even as the company implemented price increases, enabling it to offset input cost inflation through strategic pricing and inventory management.

Financial Highlights

The Board of Directors approved the unaudited financial results on August 4, 2026. Statutory auditors B S R & Co. LLP issued an unmodified limited review report on the standalone and consolidated figures. Standalone net sales grew by 22.2% to ₹4,237 crore, with standalone net profit rising 27.7% to ₹830 crore. Consolidated EBITDA stood at ₹1,194 crore, reflecting a margin expansion of 120 basis points to 26.3% from 25.1% in Q1FY26.

Operational Performance and Segment Growth

Both key business segments delivered volume growth well ahead of market estimates. The Consumer & Bazaar (C&B) segment, which includes adhesives like Fevicol and sealants like M-Seal, delivered standout performance with volume growth of 22.5% against an estimate of 13%. C&B revenue grew by 22.5% to ₹3,458 crore (standalone basis), supported by an underlying volume growth (UVG) of 12.2%. Profit before interest and tax (PBIT) for this segment rose 24.7% to ₹1,127 crore, with PBIT margins improving to 32.6% from 32.0%.

The Business-to-Business (B2B) segment also surpassed expectations, with volumes growing 16% year-on-year against an estimate of 10%. B2B revenue rose to ₹821 crore from ₹708 crore in the corresponding period last year. UVG in this segment was 7.3%, driven by domestic double-digit growth of 10.4%, while exports contracted by 8.4% due to geopolitical conditions. B2B PBIT increased by 29.2% to ₹170 crore, with margins expanding to 20.7% from 18.5%.

Margin Dynamics and Strategic Moves

While top-line growth was strong, gross margins faced headwinds. Standalone gross margin contracted by approximately 90 basis points to 52.5% from 53.4% in Q1FY26, attributed to the inflationary impact of the West Asia crisis on input costs. Similarly, consolidated gross margin declined by ~70 basis points to 53.3% from 54.0%. Despite this, EBITDA margins expanded, supported by the twin benefits of low-cost inventory and price hikes implemented across all categories. Standalone EBITDA margin improved by ~80 basis points to 26.4% from 25.6% in Q1FY26.

Sudhanshu Vats, Managing Director, noted that disciplined execution helped manage volatility effectively. "We have commenced FY27 on a strong footing, with broad-based growth across both Consumer & Bazaar and Business-to-Business segments," Vats stated. He emphasized that investments in brand building and supply chain capabilities remain key to sustaining momentum amidst global supply chain disruptions and raw material inflation.

Management Guidance: Concall Update

Despite the strong Q1FY27 performance, management has chosen not to revise its EBITDA margin guidance range of 20% to 24%, preferring to maintain a corridor that provides operating flexibility in light of ongoing global risks and uncertainties. The key guidance parameters are summarised below.

Management acknowledged that Q1 margins benefited from proactive pricing actions and some lower-cost inventory, factors that may moderate in Q2. However, the company expects to manage full-year margins well within the guided range, potentially reaching the middle to higher end if crude oil and broader commodity volatility does not escalate. On volume growth, Pidilite aims for double-digit underlying volume growth, targeting its core growth categories to expand at 1.5x to 2x India's real GDP growth, which management hypothesizes to be in the 6% to 6.5% range.

What the Numbers Show

The divergence between revenue growth (21.3%) and underlying volume growth (11.3%) highlights the significant contribution of price increases to top-line expansion. This pricing power, combined with the benefit of low-cost inventory, allowed Pidilite to not only pass on input cost inflation but also expand operating margins. The simultaneous beat in both C&B and B2B segment volumes against estimates, alongside improvement in segment margins, indicates successful operational leverage across the portfolio. However, the contraction in gross margins serves as a cautionary signal regarding persistent input cost pressures, and management's decision to retain the 20% to 24% margin guidance corridor reflects a measured approach to navigating continued global supply chain and commodity uncertainties.

Pidilite Industries posted a standalone net profit of ₹829.87 crore for the quarter ended June 30, 2026, marking a 27.7% increase from ₹649.80 crore in the same period last year. The Mumbai-based chemical and adhesive manufacturer saw its total income from operations rise 21.9% to ₹4,343.65 crore, up from ₹3,563.48 crore in Q1FY25. Consolidated net profit also grew 30.3% to ₹883.51 crore, reflecting robust demand across its core product portfolio including Fevicol, Dr. Fixit, and Araldite.

The Board of Directors approved the unaudited financial results at a meeting held on August 4, 2026, following review by the Audit Committee. The results were filed with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory auditors carried out the limited review as required. The full format of the financial results is available on the company’s website and the respective stock exchange portals.

Financial Performance Highlights

Standalone earnings per share (EPS) stood at ₹8.15, compared to ₹6.39 in the corresponding quarter of FY25. Consolidated basic EPS was ₹8.57, up from ₹6.61. The equity share capital remained unchanged at ₹101.78 crore for both standalone and consolidated entities, having been adjusted in prior periods.

What the Numbers Show

The divergence between revenue growth (21.9%) and profit growth (27.7%) indicates improved operating leverage during the quarter. With no exceptional items impacting the bottom line, the profit acceleration suggests better cost management or favorable product mix shifts. The consistent growth trajectory across both standalone and consolidated metrics underscores stable performance across subsidiaries and joint ventures.

Reserves excluding revaluation reserve stood at ₹10,563.59 crore on a standalone basis and ₹10,730.39 crore on a consolidated basis as per the audited balance sheet of the previous year. These figures reflect the company’s accumulated retained earnings and financial resilience over time.